Cytosorbents (CTSO) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026)
Cytosorbents (CTSO) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 12.44% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 6.92% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 8.48% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 19.21% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 6.67% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 8.23% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 6.21% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -1.40% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 5.69% |
| 10 | Cytosorbents | 21.41 Mn | 17.00 Mn | 7.05 Mn | -15.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -15.28% |
| Mar 31, 2026 | -13.91% |
| Dec 31, 2025 | -13.10% |
| Sep 30, 2025 | -11.62% |
| Jun 30, 2025 | -10.16% |
| Mar 31, 2025 | -10.52% |
| Dec 31, 2024 | -10.48% |
| Sep 30, 2024 | -9.84% |
| Jun 30, 2024 | -10.26% |
| Mar 31, 2024 | -8.85% |
| Dec 31, 2023 | -6.39% |
| Sep 30, 2023 | -4.01% |
| Jun 30, 2023 | 2.76% |
| Mar 31, 2023 | 36.26% |
| Dec 31, 2022 | 108.57% |
| Sep 30, 2022 | 181.95% |
| Jun 30, 2022 | 234.16% |
| Mar 31, 2022 | 226.36% |
| Dec 31, 2021 | 142.97% |
| Sep 30, 2021 | 82.87% |